Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPHOSPHAMIDE Cause Hypophysitis? 38 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Hypophysitis have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 0.0% of all adverse event reports for CYCLOPHOSPHAMIDE.

38
Reports of Hypophysitis with CYCLOPHOSPHAMIDE
0.0%
of all CYCLOPHOSPHAMIDE reports
0
Deaths
28
Hospitalizations

How Dangerous Is Hypophysitis From CYCLOPHOSPHAMIDE?

Of the 38 reports, 28 (73.7%) required hospitalization, and 20 (52.6%) were considered life-threatening.

Is Hypophysitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYCLOPHOSPHAMIDE. However, 38 reports have been filed with the FAERS database.

What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?

Off label use (12,578) Febrile neutropenia (11,318) Drug ineffective (8,142) Neutropenia (7,352) Disease progression (7,100) Pyrexia (6,126) Product use in unapproved indication (5,750) Thrombocytopenia (4,669) Pneumonia (4,595) Nausea (4,561)

What Other Drugs Cause Hypophysitis?

IPILIMUMAB (981) NIVOLUMAB (755) PEMBROLIZUMAB (411) CARBOPLATIN (144) ATEZOLIZUMAB (125) PACLITAXEL (110) BEVACIZUMAB (61) DURVALUMAB (60) PEMETREXED (51) LENVATINIB (32)

Which CYCLOPHOSPHAMIDE Alternatives Have Lower Hypophysitis Risk?

CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOSERINE CYCLOPHOSPHAMIDE vs CYCLOSPORINE

Related Pages

CYCLOPHOSPHAMIDE Full Profile All Hypophysitis Reports All Drugs Causing Hypophysitis CYCLOPHOSPHAMIDE Demographics